Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
12/29/1997 | EP0813876A1 Cyclosporin-containing soft capsule preparations |
12/29/1997 | EP0813871A1 Berberine derivates for inhibiting production of HSP47 |
12/29/1997 | EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
12/29/1997 | EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders |
12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
12/29/1997 | EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives |
12/29/1997 | EP0771195A4 Method of inhibiting nitric oxide formation |
12/24/1997 | WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins |
12/24/1997 | WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
12/24/1997 | WO1997048693A1 Isocoumarin derivatives and use thereof in drugs |
12/24/1997 | WO1997048417A1 Vaccine to prevent streptococcal endocarditis |
12/24/1997 | WO1997048410A1 Cyclosporin-containing soft capsule preparations |
12/24/1997 | WO1997048376A1 Clear cosmetic sticks and process for its preparation |
12/24/1997 | WO1997048368A2 Naphthyridines which affect il-4 and g-csf |
12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
12/24/1997 | WO1997038699A3 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
12/24/1997 | WO1997025333A3 Macrocyclic compounds made from suboxide units |
12/24/1997 | CN1168697A Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
12/24/1997 | CN1168679A Monoclonal antibody fragments having immunosuppressant activity |
12/24/1997 | CN1168678A Method of treating diabetes mellitus using KGF |
12/24/1997 | CN1168677A Novel peptides derived from autoantigent for use in immunotherapy of autoimmune diseases |
12/24/1997 | CN1168667A Pyridopyrimidones, quinolines and fused N-heretocycles as bradykinin antagonists |
12/24/1997 | CN1168633A Boronic ester and acid compounds, synthesis and uses |
12/24/1997 | CN1168372A 1, 2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
12/24/1997 | CN1036779C Aryl naphthenes derivant and its use |
12/24/1997 | CA2258011A1 Vaccine to prevent streptococcal endocarditis |
12/24/1997 | CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins |
12/24/1997 | CA2257289A1 Clear cosmetic sticks and process for its preparation |
12/23/1997 | US5700947 Having reduced side effects |
12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |
12/23/1997 | US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
12/23/1997 | US5700816 Antiarthritic agents |
12/23/1997 | US5700807 Endothelin receptor antagonists |
12/23/1997 | US5700801 Antiinflammatory agents, bone disorders |
12/23/1997 | US5700788 Treatment of hiv |
12/23/1997 | US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines |
12/23/1997 | CA2126972C Styrene derivative and salts thereof |
12/18/1997 | WO1997047744A2 T-cell selective interleukin-4 agonists |
12/18/1997 | WO1997047644A1 T cell antigen receptor peptides |
12/18/1997 | WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity |
12/18/1997 | WO1997047604A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same |
12/18/1997 | WO1997047577A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
12/18/1997 | WO1997047283A1 Combination of acid protease enzymes and acidic buffers and uses thereof |
12/18/1997 | WO1997035982A3 Monocyte chemotactic protein-5 materials and methods |
12/18/1997 | WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
12/17/1997 | EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists |
12/17/1997 | EP0812587A1 Transdermal compositions containing Nimesulide |
12/17/1997 | EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
12/17/1997 | EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors |
12/17/1997 | EP0812203A1 Inhibitors of geranylgeranyl-protein transferase |
12/17/1997 | EP0812193A1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent |
12/17/1997 | EP0651743B1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
12/17/1997 | CN1168094A Directly compressible high load acetaminophen formulations |
12/17/1997 | CN1167752A Novel retinoids derivs. |
12/16/1997 | US5698706 Heterocyclic amides and methods of use |
12/16/1997 | US5698690 Hydroxamic acid derivatives with tricyclic substitution |
12/16/1997 | US5698594 Treatment and prevention of risk factors for cardiovascular diseases |
12/16/1997 | US5698578 Protein kinase C inhibitors |
12/16/1997 | US5698568 Substance p antagonists |
12/16/1997 | US5698552 Hetrazepinoid amides |
12/16/1997 | US5698551 Treatment of diabetic neuropathy, migraines, neurogenic inflammation, rheumatic arthritis and insulin resistance |
12/16/1997 | US5698523 Acylated enol derivatives as prodrugs of elastase inhibitors |
12/16/1997 | US5698445 Human PAK65 |
12/16/1997 | US5698428 Human PAK65 |
12/16/1997 | US5698405 Coupling immunogenic agent with a carbohydrate polymer |
12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
12/16/1997 | US5698196 Antibodies specific for neutrophic chemotactic factor |
12/16/1997 | CA2107479C Pyrazolo[1,5-a]pyrimidine derivatives and anti-inflammatory agent containing the same |
12/16/1997 | CA2086432C 3-(1-substitutedpyrazoyl)-2-oxindole derivatives |
12/11/1997 | WO1997046686A2 Tumor necrosis factor-related polypeptide |
12/11/1997 | WO1997046579A1 Neuropeptide y agonists |
12/11/1997 | WO1997046578A1 Peptide derivatives |
12/11/1997 | WO1997046561A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity |
12/11/1997 | WO1997046548A1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
12/11/1997 | WO1997046524A1 Novel pyrrole derivatives |
12/11/1997 | WO1997046522A1 Novel vitamin d analogues |
12/11/1997 | WO1997046245A1 Pharmaceutical composition which is stable during storage and contains a thymus extract |
12/11/1997 | DE19622422A1 Lagerungsstabile pharmazeutische Zusammensetzung mit immun - modulierenden und antiinflammatorischen Eigenschaften sowie ein Verfahren zu dessen Herstellung Storage stable pharmaceutical composition having immuno - modulatory and anti-inflammatory properties and a process for its preparation |
12/11/1997 | CA2257424A1 Neuropeptide y agonists |
12/11/1997 | CA2256464A1 Tumor necrosis factor-related polypeptide |
12/11/1997 | CA2252417A1 Peptide derivatives |
12/10/1997 | EP0811634A1 Fluorinated sialyl-lewis x derivatives and intermediates for synthesis thereof |
12/10/1997 | EP0811376A1 Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of chronic inflammatory bowel diseases |
12/10/1997 | EP0811159A1 A process for identifiying pharmaceutically active agents using an epitope-tagged library |
12/10/1997 | EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies |
12/10/1997 | EP0810991A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
12/10/1997 | EP0810875A1 Multifunctional enzyme |
12/10/1997 | EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity |
12/10/1997 | EP0708766B1 Use of coumarins as pla 2-inhibitors, new coumarins, process for preparing the same and medicaments |
12/10/1997 | EP0674625B1 Amino-substituted pyrazoles having crf antagonistic activity |
12/10/1997 | EP0355088B1 Sulphated polysaccharides having anti-metastatic activity |
12/10/1997 | CN1167505A Tie-2 ligands, methods of making and uses thereof |
12/10/1997 | CN1036652C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present |
12/09/1997 | US5696267 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
12/09/1997 | US5696165 Composition of s(-) sodium ibuprofen |
12/09/1997 | US5696141 Isoxazoline compounds as 5-lipoxygenase inhibitors |
12/09/1997 | US5696128 Adjustment prolactin profile |
12/09/1997 | US5696123 Neurokinin antagonists |